{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T13:39:15Z","timestamp":1791639555353,"version":"4.3.4"},"reference-count":168,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T00:00:00Z","timestamp":1633392000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004694","name":"Kaohsiung Medical University","doi-asserted-by":"publisher","award":["KMU-TC109B02"],"award-info":[{"award-number":["KMU-TC109B02"]}],"id":[{"id":"10.13039\/501100004694","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.biopha.2021.112304","type":"journal-article","created":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T00:16:05Z","timestamp":1633738565000},"page":"112304","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Targets and strategies for vaccine development against dengue viruses"],"prefix":"10.1016","volume":"144","author":[{"given":"Wen-Hung","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aspiro Nayim","family":"Urbina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Yen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zih-Syuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanchai","family":"Assavalapsakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arunee","family":"Thitithanyanont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Liang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Hsu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Fan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.biopha.2021.112304_bib1","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1056\/NEJMra1110265","article-title":"Dengue","volume":"366","author":"Simmons","year":"2012","journal-title":"New Engl. J. Med."},{"issue":"7446","key":"10.1016\/j.biopha.2021.112304_bib2","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue","volume":"496","author":"Bhatt","year":"2013","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.biopha.2021.112304_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001760","article-title":"Refining the global spatial limits of dengue virus transmission by evidence-based consensus","volume":"6","author":"Brady","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"1","key":"10.1016\/j.biopha.2021.112304_bib4","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4269\/ajtmh.1952.1.30","article-title":"Research on dengue during World War II","volume":"1","author":"Sabin","year":"1952","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"6","key":"10.1016\/j.biopha.2021.112304_bib5","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.jmii.2020.03.007","article-title":"Dengue hemorrhagic fever \u2013 a systemic literature review of current perspectives on pathogenesis, prevention and control","volume":"53","author":"Wang","year":"2020","journal-title":"J. Microbiol. Immunol. Infect."},{"issue":"6","key":"10.1016\/j.biopha.2021.112304_bib6","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.jmii.2016.08.024","article-title":"Analyses of clinical and laboratory characteristics of dengue adults at their hospital presentations based on the World Health Organization clinical-phase framework: emphasizing risk of severe dengue in the elderly","volume":"51","author":"Kuo","year":"2018","journal-title":"J. Microbiol. Immunol. Infect."},{"issue":"6365","key":"10.1016\/j.biopha.2021.112304_bib7","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1126\/science.aan6836","article-title":"Antibody-dependent enhancement of severe dengue disease in humans","volume":"358","author":"Katzelnick","year":"2017","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.biopha.2021.112304_bib8","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S1473-3099(10)70166-3","article-title":"Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes","volume":"10","author":"Halstead","year":"2010","journal-title":"Lancet Infect. Dis."},{"issue":"5979","key":"10.1016\/j.biopha.2021.112304_bib9","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1126\/science.1185181","article-title":"Cross-reacting antibodies enhance dengue virus infection in humans","volume":"328","author":"Dejnirattisai","year":"2010","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.biopha.2021.112304_bib10","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.4049\/jimmunol.147.9.3139","article-title":"Antibody-dependent enhancement of dengue virus infection mediated by bispecific antibodies against cell surface molecules other than Fc gamma receptors","volume":"147","author":"Mady","year":"1991","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.biopha.2021.112304_bib11","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.3390\/v2122649","article-title":"The complexity of antibody-dependent enhancement of dengue virus infection","volume":"2","author":"Guzman","year":"2010","journal-title":"Viruses"},{"issue":"5","key":"10.1016\/j.biopha.2021.112304_bib12","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0092-8674(02)00660-8","article-title":"Structure of dengue virus: implications for flavivirus organization, maturation, and fusion","volume":"108","author":"Kuhn","year":"2002","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.biopha.2021.112304_bib13","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1146\/annurev-virology-110615-042334","article-title":"Properties and functions of the dengue virus capsid protein","volume":"3","author":"Byk","year":"2016","journal-title":"Annu. Rev. Virol."},{"issue":"46","key":"10.1016\/j.biopha.2021.112304_bib14","doi-asserted-by":"crossref","first-page":"18662","DOI":"10.1073\/pnas.1310962110","article-title":"Atomic-level functional model of dengue virus Envelope protein infectivity","volume":"110","author":"Christian","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5871","key":"10.1016\/j.biopha.2021.112304_bib15","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1126\/science.1153264","article-title":"Structure of the immature dengue virus at low pH primes proteolytic maturation","volume":"319","author":"Yu","year":"2008","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.biopha.2021.112304_bib16","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.mib.2008.06.004","article-title":"Structural proteomics of dengue virus","volume":"11","author":"Perera","year":"2008","journal-title":"Curr. Opin. Microbiol."},{"issue":"1","key":"10.1016\/j.biopha.2021.112304_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.micinf.2006.09.009","article-title":"The envelope glycoprotein domain III of dengue virus serotypes 1 and 2 inhibit virus entry","volume":"9","author":"Chin","year":"2007","journal-title":"Microbes Infect."},{"issue":"1","key":"10.1016\/j.biopha.2021.112304_bib18","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.virol.2011.01.030","article-title":"Amino acid changes within the E protein hinge region that affect dengue virus type 2 infectivity and fusion","volume":"413","author":"Butrapet","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.biopha.2021.112304_bib19","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.52384","article-title":"Broadly neutralizing human antibodies against dengue virus identified by single B cell transcriptomics","volume":"8","author":"Durham","year":"2019","journal-title":"Elife"},{"issue":"1","key":"10.1016\/j.biopha.2021.112304_bib20","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12929-018-0462-0","article-title":"Dengue virus non-structural protein 1: a pathogenic factor, therapeutic target, and vaccine candidate","volume":"25","author":"Chen","year":"2018","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.biopha.2021.112304_bib21","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1423-0127-20-42","article-title":"Re-evaluation of the pathogenic roles of nonstructural protein 1 and its antibodies during dengue virus infection","volume":"20","author":"Chuang","year":"2013","journal-title":"J. Biomed. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2021.112304_bib22","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1128\/JCM.40.02.376-381.2002","article-title":"Enzyme-linked immunosorbent assay specific to Dengue virus type 1 nonstructural protein NS1 reveals circulation of the antigen in the blood during the acute phase of disease in patients experiencing primary or secondary infections","volume":"40","author":"Alcon","year":"2002","journal-title":"J. Clin. Microbiol."},{"issue":"8","key":"10.1016\/j.biopha.2021.112304_bib23","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1086\/343813","article-title":"High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever","volume":"186","author":"Libraty","year":"2002","journal-title":"J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.biopha.2021.112304_bib24","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1128\/JCM.38.3.1053-1057.2000","article-title":"An antigen capture enzyme-linked immunosorbent assay reveals high levels of the dengue virus protein NS1 in the sera of infected patients","volume":"38","author":"Young","year":"2000","journal-title":"J. Clin. Microbiol."},{"issue":"304","key":"10.1016\/j.biopha.2021.112304_bib25","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1126\/scitranslmed.aaa3863","article-title":"Dengue virus NS1 protein activates cells via Toll-like receptor 4 and disrupts endothelial cell monolayer integrity","volume":"7","author":"Modhiran","year":"2015","journal-title":"Sci. Transl. Med."},{"issue":"5","key":"10.1016\/j.biopha.2021.112304_bib26","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/icb.2017.5","article-title":"Dengue virus NS1 protein activates immune cells via TLR4 but not TLR2 or TLR6","volume":"95","author":"Modhiran","year":"2017","journal-title":"Immunol. Cell Biol."},{"issue":"11","key":"10.1016\/j.biopha.2021.112304_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006673","article-title":"Dengue virus NS1 cytokine-independent vascular leak is dependent on endothelial glycocalyx components","volume":"13","author":"Glasner","year":"2017","journal-title":"PLoS Pathog."},{"issue":"31","key":"10.1016\/j.biopha.2021.112304_bib28","doi-asserted-by":"crossref","first-page":"E4256","DOI":"10.1073\/pnas.1505956112","article-title":"Dengue virus infection elicits highly polarized CX3CR1+ cytotoxic CD4+ T cells associated with protective immunity","volume":"112","author":"Weiskopf","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"10","key":"10.1016\/j.biopha.2021.112304_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025685","article-title":"Induction of a protective response in mice by the dengue virus NS3 protein using DNA vaccines","volume":"6","author":"Costa","year":"2011","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.biopha.2021.112304_bib30","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/femsre\/fuu004","article-title":"Poian, Receptors and routes of dengue virus entry into the host cells","volume":"39","author":"Cruz-Oliveira","year":"2015","journal-title":"FEMS Microbiol. Rev."},{"issue":"11","key":"10.1016\/j.biopha.2021.112304_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166474","article-title":"Dengue virus infection is through a cooperative interaction between a mannose receptor and CLEC5A on macrophage as a multivalent hetero-complex","volume":"11","author":"Lo","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2021.112304_bib32","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.coviro.2020.09.004","article-title":"Dengue vaccine development by the year 2020: challenges and prospects","volume":"43","author":"Wilder-Smith","year":"2020","journal-title":"Curr. Opin. Virol."},{"issue":"7","key":"10.1016\/j.biopha.2021.112304_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med."},{"issue":"1","key":"10.1016\/j.biopha.2021.112304_bib34","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrmicro1067","article-title":"A structural perspective of the flavivirus life cycle","volume":"3","author":"Mukhopadhyay","year":"2005","journal-title":"Nat. Rev. Microbiol."},{"issue":"12","key":"10.1016\/j.biopha.2021.112304_bib35","doi-asserted-by":"crossref","first-page":"6986","DOI":"10.1073\/pnas.0832193100","article-title":"A ligand-binding pocket in the dengue virus envelope glycoprotein","volume":"100","author":"Modis","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"11","key":"10.1016\/j.biopha.2021.112304_bib36","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/nsb990","article-title":"Visualization of membrane protein domains by cryo-electron microscopy of dengue virus","volume":"10","author":"Zhang","year":"2003","journal-title":"Nat. Struct. Biol."},{"issue":"2","key":"10.1016\/j.biopha.2021.112304_bib37","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.virol.2010.07.024","article-title":"Domain-III FG loop of the dengue virus type 2 envelope protein is important for infection of mammalian cells and Aedes aegypti mosquitoes","volume":"406","author":"Erb","year":"2010","journal-title":"Virology"},{"issue":"10","key":"10.1016\/j.biopha.2021.112304_bib38","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1111\/j.1462-5822.2009.01345.x","article-title":"Alternative infectious entry pathways for dengue virus serotypes into mammalian cells","volume":"11","author":"Acosta","year":"2009","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.biopha.2021.112304_bib39","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/825039","article-title":"Progress in the identification of dengue virus entry\/fusion inhibitors","volume":"2014","author":"De La Guardia","year":"2014","journal-title":"Biomed. Res. Int."},{"issue":"1","key":"10.1016\/j.biopha.2021.112304_bib40","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1128\/JVI.78.1.378-388.2004","article-title":"An external loop region of domain III of dengue virus type 2 envelope protein is involved in serotype-specific binding to mosquito but not mammalian cells","volume":"78","author":"Hung","year":"2004","journal-title":"J. Virol."},{"issue":"8","key":"10.1016\/j.biopha.2021.112304_bib41","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/nm0897-866","article-title":"Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate","volume":"3","author":"Chen","year":"1997","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.biopha.2021.112304_bib42","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.virusres.2008.07.022","article-title":"Characterization of the interaction of domain III of the envelope protein of dengue virus with putative receptors from CHO cells","volume":"137","author":"Huerta","year":"2008","journal-title":"Virus Res."},{"issue":"5","key":"10.1016\/j.biopha.2021.112304_bib43","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1128\/JVI.78.5.2648-2652.2004","article-title":"Contribution of disulfide bridging to epitope expression of the dengue type 2 virus envelope glycoprotein","volume":"78","author":"Roehrig","year":"2004","journal-title":"J. Virol."},{"issue":"16","key":"10.1016\/j.biopha.2021.112304_bib44","doi-asserted-by":"crossref","first-page":"7769","DOI":"10.1128\/JVI.75.16.7769-7773.2001","article-title":"Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells","volume":"75","author":"Crill","year":"2001","journal-title":"J. Virol."},{"issue":"Pt 1","key":"10.1016\/j.biopha.2021.112304_bib45","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1099\/vir.0.037317-0","article-title":"Residues in domain III of the dengue virus envelope glycoprotein involved in cell-surface glycosaminoglycan binding","volume":"93","author":"Watterson","year":"2012","journal-title":"J. Gen. Virol."},{"issue":"4","key":"10.1016\/j.biopha.2021.112304_bib46","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41577-019-0123-x","article-title":"Adaptive immune responses to primary and secondary dengue virus infections","volume":"19","author":"John","year":"2019","journal-title":"Nat. Rev. Immunol."},{"issue":"12","key":"10.1016\/j.biopha.2021.112304_bib47","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.3390\/v3122374","article-title":"The human antibody response to dengue virus infection","volume":"3","author":"Wahala","year":"2011","journal-title":"Viruses"},{"issue":"24","key":"10.1016\/j.biopha.2021.112304_bib48","doi-asserted-by":"crossref","first-page":"11122","DOI":"10.1128\/JVI.01096-16","article-title":"Protective capacity of the human anamnestic antibody response during acute dengue virus infection","volume":"90","author":"Xu","year":"2016","journal-title":"J. Virol."},{"issue":"8","key":"10.1016\/j.biopha.2021.112304_bib49","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/nri3014","article-title":"Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms","volume":"11","author":"Rothman","year":"2011","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2021.112304_bib50","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.virol.2007.05.042","article-title":"Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus","volume":"366","author":"Gromowski","year":"2007","journal-title":"Virology"},{"issue":"3","key":"10.1016\/j.biopha.2021.112304_bib51","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/nsmb.1382","article-title":"Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins","volume":"15","author":"Lok","year":"2008","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2021.112304_bib52","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/cmi.2015.76","article-title":"Guiding dengue vaccine development using knowledge gained from the success of the yellow fever vaccine","volume":"13","author":"Liang","year":"2016","journal-title":"Cell. Mol. Immunol."},{"issue":"7","key":"10.1016\/j.biopha.2021.112304_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003947","article-title":"Dengue E protein domain III-Based DNA immunisation induces strong antibody responses to all four viral serotypes","volume":"9","author":"Poggianella","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"2","key":"10.1016\/j.biopha.2021.112304_bib54","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.antiviral.2013.03.008","article-title":"The flavivirus NS1 protein: molecular and structural biology, immunology, role in pathogenesis and application as a diagnostic biomarker","volume":"98","author":"Muller","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.biopha.2021.112304_bib55","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12985-016-0590-7","article-title":"Flavivirus NS1: a multifaceted enigmatic viral protein","volume":"13","author":"Rastogi","year":"2016","journal-title":"Virol. J."},{"key":"10.1016\/j.biopha.2021.112304_bib56","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.3389\/fimmu.2019.01651","article-title":"The dual role of the antibody response against the flavivirus non-structural protein 1 (NS1) in protection and immuno-pathogenesis","volume":"10","author":"Reyes-Sandoval","year":"2019","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.biopha.2021.112304_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005277","article-title":"Dengue virus non-structural protein 1 modulates infectious particle production via interaction with the structural proteins","volume":"11","author":"Scaturro","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.biopha.2021.112304_bib58","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.virol.2015.11.020","article-title":"The dengue virus non-structural protein 1 (NS1) is secreted efficiently from infected mosquito cells","volume":"488","author":"Alcala","year":"2016","journal-title":"Virology"},{"issue":"8","key":"10.1016\/j.biopha.2021.112304_bib59","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1099\/jgv.0.000881","article-title":"The dengue virus non-structural protein 1 (NS1) is secreted from infected mosquito cells via a non-classical caveolin-1-dependent pathway","volume":"98","author":"Alcala","year":"2017","journal-title":"J. Gen. Virol."},{"issue":"6173","key":"10.1016\/j.biopha.2021.112304_bib60","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1126\/science.1247749","article-title":"Flavivirus NS1 structures reveal surfaces for associations with membranes and the immune system","volume":"343","author":"Akey","year":"2014","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.biopha.2021.112304_bib61","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01985-18","article-title":"The dengue virus nonstructural protein 1 (NS1) is secreted from mosquito cells in association with the intracellular cholesterol transporter chaperone caveolin complex","volume":"93","author":"Rosales Ramirez","year":"2019","journal-title":"J. Virol."},{"issue":"19","key":"10.1016\/j.biopha.2021.112304_bib62","doi-asserted-by":"crossref","first-page":"8003","DOI":"10.1073\/pnas.1017338108","article-title":"Secreted dengue virus nonstructural protein NS1 is an atypical barrel-shaped high-density lipoprotein","volume":"108","author":"Gutsche","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"17","key":"10.1016\/j.biopha.2021.112304_bib63","doi-asserted-by":"crossref","first-page":"11403","DOI":"10.1128\/JVI.79.17.11403-11411.2005","article-title":"The secreted form of dengue virus nonstructural protein NS1 is endocytosed by hepatocytes and accumulates in late endosomes: implications for viral infectivity","volume":"79","author":"Alcon-LePoder","year":"2005","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.biopha.2021.112304_bib64","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/bies.201400182","article-title":"Structure-guided insights on the role of NS1 in flavivirus infection","volume":"37","author":"Akey","year":"2015","journal-title":"Bioessays"},{"issue":"11","key":"10.1016\/j.biopha.2021.112304_bib65","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1073\/pnas.1322036111","article-title":"Structural basis of Flavivirus NS1 assembly and antibody recognition","volume":"111","author":"Edeling","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"8","key":"10.1016\/j.biopha.2021.112304_bib66","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1086\/500949","article-title":"Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement","volume":"193","author":"Avirutnan","year":"2006","journal-title":"J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.biopha.2021.112304_bib67","doi-asserted-by":"crossref","first-page":"446","DOI":"10.4269\/ajtmh.12-0023","article-title":"Determination of viremia and concentration of circulating nonstructural protein 1 in patients infected with dengue virus in Mexico","volume":"88","author":"de la Cruz-Hernandez","year":"2013","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"13","key":"10.1016\/j.biopha.2021.112304_bib68","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJMoa1506223","article-title":"Efficacy and long-term safety of a dengue vaccine in regions of endemic disease","volume":"373","author":"Hadinegoro","year":"2015","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.biopha.2021.112304_bib69","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.572681","article-title":"Antibody-dependent enhancement: a challenge for developing a safe dengue vaccine","volume":"10","author":"Shukla","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.biopha.2021.112304_bib70","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/0470058005.ch17","article-title":"Secretion of flaviviral non-structural protein NS1: from diagnosis to pathogenesis","volume":"277","author":"Alcon-LePoder","year":"2006","journal-title":"Novartis Found. Symp."},{"issue":"9","key":"10.1016\/j.biopha.2021.112304_bib71","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0163240","article-title":"Aspects of T cell-mediated immunity induced in mice by a DNA vaccine based on the dengue-NS1 antigen after challenge by the intracerebral route","volume":"11","author":"Oliveira","year":"2016","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.biopha.2021.112304_bib72","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004277","article-title":"Cooperation between CD4+ T cells and humoral immunity is critical for protection against dengue using a DNA vaccine based on the NS1 antigen","volume":"9","author":"Goncalves","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"5","key":"10.1016\/j.biopha.2021.112304_bib73","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1258\/ebm.2011.010339","article-title":"Molecular mimicry between virus and host and its implications for dengue disease pathogenesis","volume":"236","author":"Lin","year":"2011","journal-title":"Exp. Biol. Med."},{"issue":"3","key":"10.1016\/j.biopha.2021.112304_bib74","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.4049\/jimmunol.1500057","article-title":"Dengue virus nonstructural protein 1-induced antibodies cross-react with human plasminogen and enhance its activation","volume":"196","author":"Chuang","year":"2016","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.biopha.2021.112304_bib75","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s007050050127","article-title":"The dengue virus nonstructural-1 protein (NS1) generates antibodies to common epitopes on human blood clotting, integrin\/adhesin proteins and binds to human endothelial cells: potential implications in haemorrhagic fever pathogenesis","volume":"142","author":"Falconar","year":"1997","journal-title":"Arch. Virol."},{"issue":"1","key":"10.1016\/j.biopha.2021.112304_bib76","doi-asserted-by":"crossref","first-page":"6975","DOI":"10.1038\/s41598-017-07308-3","article-title":"Antibodies against modified NS1 wing domain peptide protect against dengue virus infection","volume":"7","author":"Lai","year":"2017","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.biopha.2021.112304_bib77","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines9060622","article-title":"Flavivirus NS1 and its potential in vaccine development","volume":"9","author":"Carpio","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.biopha.2021.112304_bib78","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3181\/00379727-60-15141","article-title":"Cause of an outbreak of encephalitis established by means of complement-fixation tests","volume":"60","author":"Hodes","year":"1945","journal-title":"Proc. Soc. Exp. Biol. Med."},{"issue":"4","key":"10.1016\/j.biopha.2021.112304_bib79","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.4049\/jimmunol.135.4.2805","article-title":"Protection against 17D yellow fever encephalitis in mice by passive transfer of monoclonal antibodies to the nonstructural glycoprotein gp48 and by active immunization with gp48","volume":"135","author":"Schlesinger","year":"1985","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2021.112304_bib80","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1128\/jvi.60.3.1153-1155.1986","article-title":"Protection against yellow fever in monkeys by immunization with yellow fever virus nonstructural protein NS1","volume":"60","author":"Schlesinger","year":"1986","journal-title":"J. Virol."},{"issue":"Pt 3","key":"10.1016\/j.biopha.2021.112304_bib81","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1099\/0022-1317-68-3-853","article-title":"Protection of mice against dengue 2 virus encephalitis by immunization with the dengue 2 virus non-structural glycoprotein NS1","volume":"68","author":"Schlesinger","year":"1987","journal-title":"J. Gen. Virol."},{"issue":"13","key":"10.1016\/j.biopha.2021.112304_bib82","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/0264-410X(94)00059-V","article-title":"Mice immunized with a dengue type 2 virus E and NS1 fusion protein made in Escherichia coli are protected against lethal dengue virus infection","volume":"13","author":"Srivastava","year":"1995","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.biopha.2021.112304_bib83","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1099\/jgv.0.001101","article-title":"Characterization of neutralizing epitopes in antigenic site B of recently circulating influenza A(H3N2) viruses","volume":"99","author":"Beer","year":"2018","journal-title":"J. Gen. Virol."},{"issue":"25\u201326","key":"10.1016\/j.biopha.2021.112304_bib84","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1016\/S0264-410X(03)00310-4","article-title":"Evaluation of protective efficacy and immune mechanisms of using a non-structural protein NS1 in DNA vaccine against dengue 2 virus in mice","volume":"21","author":"Wu","year":"2003","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.biopha.2021.112304_bib85","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00705-010-0652-x","article-title":"A plasmid encoding parts of the dengue virus E and NS1 proteins induces an immune response in a mouse model","volume":"155","author":"Mellado-Sanchez","year":"2010","journal-title":"Arch. Virol."},{"issue":"2","key":"10.1016\/j.biopha.2021.112304_bib86","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.vaccine.2005.07.059","article-title":"Protection against dengue type 2 virus induced in mice immunized with a DNA plasmid encoding the non-structural 1 (NS1) gene fused to the tissue plasminogen activator signal sequence","volume":"24","author":"Costa","year":"2006","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.biopha.2021.112304_bib87","doi-asserted-by":"crossref","first-page":"4019","DOI":"10.1128\/jvi.61.12.4019-4022.1987","article-title":"Expression of dengue virus structural proteins and nonstructural protein NS1 by a recombinant vaccinia virus","volume":"61","author":"Zhao","year":"1987","journal-title":"J. Virol."},{"issue":"9","key":"10.1016\/j.biopha.2021.112304_bib88","doi-asserted-by":"crossref","first-page":"4356","DOI":"10.1128\/jvi.64.9.4356-4363.1990","article-title":"Immunization of mice with recombinant vaccinia virus expressing authentic dengue virus nonstructural protein NS1 protects against lethal dengue virus encephalitis","volume":"64","author":"Falgout","year":"1990","journal-title":"J. Virol."},{"issue":"Pt 1","key":"10.1016\/j.biopha.2021.112304_bib89","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1099\/0022-1317-74-1-89","article-title":"Immunoreactivity and protective effects in mice of a recombinant dengue 2 Tonga virus NS1 protein produced in a baculovirus expression system","volume":"74","author":"Qu","year":"1993","journal-title":"J. Gen. Virol."},{"issue":"4","key":"10.1016\/j.biopha.2021.112304_bib90","doi-asserted-by":"crossref","first-page":"472","DOI":"10.4269\/ajtmh.1994.50.472","article-title":"Immunization of monkeys with baculovirus-dengue type-4 recombinants containing envelope and nonstructural proteins: evidence of priming and partial protection","volume":"50","author":"Eckels","year":"1994","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"8","key":"10.1016\/j.biopha.2021.112304_bib91","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1128\/jvi.62.8.3027-3031.1988","article-title":"Immunization of mice with dengue structural proteins and nonstructural protein NS1 expressed by baculovirus recombinant induces resistance to dengue virus encephalitis","volume":"62","author":"Zhang","year":"1988","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.biopha.2021.112304_bib92","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s00705-004-0430-8","article-title":"Deglycosylation of the NS1 protein of dengue 2 virus, strain 16681: construction and characterization of mutant viruses","volume":"150","author":"Crabtree","year":"2005","journal-title":"Arch. Virol."},{"issue":"42","key":"10.1016\/j.biopha.2021.112304_bib93","doi-asserted-by":"crossref","first-page":"7251","DOI":"10.1016\/j.vaccine.2011.07.020","article-title":"Development of DENVax: a chimeric dengue-2 PDK-53-based tetravalent vaccine for protection against dengue fever","volume":"29","author":"Osorio","year":"2011","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.biopha.2021.112304_bib94","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1128\/JVI.74.7.3011-3019.2000","article-title":"Attenuation markers of a candidate dengue type 2 vaccine virus, strain 16681 (PDK-53), are defined by mutations in the 5\u2019 noncoding region and nonstructural proteins 1 and 3","volume":"74","author":"Butrapet","year":"2000","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.biopha.2021.112304_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107617","article-title":"A non-structural 1 protein G53D substitution attenuates a clinically tested live dengue vaccine","volume":"31","author":"Choy","year":"2020","journal-title":"Cell Rep."},{"issue":"498","key":"10.1016\/j.biopha.2021.112304_bib96","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat7726","article-title":"A T164S mutation in the dengue virus NS1 protein is associated with greater disease severity in mice","volume":"11","author":"Chan","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.biopha.2021.112304_bib97","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.3389\/fimmu.2018.01919","article-title":"Recent developments in recombinant protein-based dengue vaccines","volume":"9","author":"Tripathi","year":"2018","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2021.112304_bib98","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.apjtm.2017.03.003","article-title":"Towards development of a universal dengue vaccine - how close are we?","volume":"10","author":"Pang","year":"2017","journal-title":"Asian Pac. J. Trop. Med."},{"issue":"4","key":"10.1016\/j.biopha.2021.112304_bib99","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines7040189","article-title":"Efficient delivery of dengue virus subunit vaccines to the skin by microprojection arrays","volume":"7","author":"Muller","year":"2019","journal-title":"Vaccines"},{"issue":"2","key":"10.1016\/j.biopha.2021.112304_bib100","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4269\/ajtmh.2001.65.159","article-title":"Short report: antibody responses of mice immunized with a tetravalent dengue recombinant protein subunit vaccine","volume":"65","author":"Simmons","year":"2001","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"3\u20134","key":"10.1016\/j.biopha.2021.112304_bib101","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s10295-013-1235-0","article-title":"Current state and recent advances in biopharmaceutical production in Escherichia coli, yeasts and mammalian cells","volume":"40","author":"Berlec","year":"2013","journal-title":"J. Ind. Microbiol. Biotechnol."},{"issue":"36","key":"10.1016\/j.biopha.2021.112304_bib102","doi-asserted-by":"crossref","first-page":"4655","DOI":"10.1016\/j.vaccine.2008.07.006","article-title":"Immunogenicity of a recombinant envelope domain III protein of dengue virus type-4 with various adjuvants in mice","volume":"26","author":"Babu","year":"2008","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.biopha.2021.112304_bib103","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1139\/w11-137","article-title":"Eliciting cross-neutralizing antibodies in mice challenged with a dengue virus envelope domain III expressed in Escherichia coli","volume":"58","author":"Yang","year":"2012","journal-title":"Can. J. Microbiol."},{"issue":"12","key":"10.1016\/j.biopha.2021.112304_bib104","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.vaccine.2014.01.041","article-title":"Recombinant lipidated dengue-4 envelope protein domain III elicits protective immunity","volume":"32","author":"Chiang","year":"2014","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.biopha.2021.112304_bib105","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.vaccine.2016.01.009","article-title":"Recombinant lipidated dengue-3 envelope protein domain III stimulates broad immune responses in mice","volume":"34","author":"Chiang","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.biopha.2021.112304_bib106","doi-asserted-by":"crossref","first-page":"30648","DOI":"10.1038\/srep30648","article-title":"Immunogenicity of a novel tetravalent vaccine formulation with four recombinant lipidated dengue envelope protein domain IIIs in mice","volume":"6","author":"Chiang","year":"2016","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.biopha.2021.112304_bib107","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1007\/s00705-014-2115-2","article-title":"A tetravalent dengue vaccine containing a mix of domain III-P64k and domain III-capsid proteins induces a protective response in mice","volume":"159","author":"Izquierdo","year":"2014","journal-title":"Arch. Virol."},{"issue":"4","key":"10.1016\/j.biopha.2021.112304_bib108","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/1348-0421.12140","article-title":"Evaluation in mice of the immunogenicity and protective efficacy of a tetravalent subunit vaccine candidate against dengue virus","volume":"58","author":"Lazo","year":"2014","journal-title":"Microbiol. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2021.112304_bib109","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0086573","article-title":"Induction of neutralizing antibodies against four serotypes of dengue viruses by MixBiEDIII, a tetravalent dengue vaccine","volume":"9","author":"Zhao","year":"2014","journal-title":"PLoS One"},{"issue":"46","key":"10.1016\/j.biopha.2021.112304_bib110","doi-asserted-by":"crossref","first-page":"6308","DOI":"10.1016\/j.vaccine.2017.09.063","article-title":"Elaboration of tetravalent antibody responses against dengue viruses using a subunit vaccine comprised of a single consensus dengue envelope sequence","volume":"35","author":"Sun","year":"2017","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.biopha.2021.112304_bib111","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12934-018-0876-0","article-title":"Comparative immunogenicity of preparations of yeast-derived dengue oral vaccine candidate","volume":"17","author":"Bal","year":"2018","journal-title":"Microb. Cell Fact."},{"issue":"33","key":"10.1016\/j.biopha.2021.112304_bib112","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1016\/j.vaccine.2015.06.067","article-title":"Preclinical development of a dengue tetravalent recombinant subunit vaccine: immunogenicity and protective efficacy in nonhuman primates","volume":"33","author":"Govindarajan","year":"2015","journal-title":"Vaccine"},{"issue":"14","key":"10.1016\/j.biopha.2021.112304_bib113","doi-asserted-by":"crossref","first-page":"7348","DOI":"10.1128\/JVI.00273-15","article-title":"Complexity of neutralizing antibodies against multiple dengue virus serotypes after heterotypic immunization and secondary infection revealed by in-depth analysis of cross-reactive antibodies","volume":"89","author":"Tsai","year":"2015","journal-title":"J. Virol."},{"issue":"17","key":"10.1016\/j.biopha.2021.112304_bib114","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1016\/j.vaccine.2020.03.008","article-title":"Comparison of purified psoralen-inactivated and formalin-inactivated dengue vaccines in mice and nonhuman primates","volume":"38","author":"Sundaram","year":"2020","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.biopha.2021.112304_bib115","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1093\/infdis\/174.6.1176","article-title":"Development of a purified, inactivated, dengue-2 virus vaccine prototype in Vero cells: immunogenicity and protection in mice and rhesus monkeys","volume":"174","author":"Putnak","year":"1996","journal-title":"J. Infect. Dis."},{"issue":"5","key":"10.1016\/j.biopha.2021.112304_bib116","doi-asserted-by":"crossref","first-page":"504","DOI":"10.4269\/ajtmh.1996.55.504","article-title":"Immunogenic and protective response in mice immunized with a purified, inactivated, Dengue-2 virus vaccine prototype made in fetal rhesus lung cells","volume":"55","author":"Putnak","year":"1996","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"35","key":"10.1016\/j.biopha.2021.112304_bib117","doi-asserted-by":"crossref","first-page":"4442","DOI":"10.1016\/j.vaccine.2005.03.042","article-title":"An evaluation of dengue type-2 inactivated, recombinant subunit, and live-attenuated vaccine candidates in the rhesus macaque model","volume":"23","author":"Robert Putnak","year":"2005","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.biopha.2021.112304_bib118","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.virol.2009.10.023","article-title":"Protection against dengue virus by non-replicating and live attenuated vaccines used together in a prime boost vaccination strategy","volume":"396","author":"Simmons","year":"2010","journal-title":"Virology"},{"issue":"12","key":"10.1016\/j.biopha.2021.112304_bib119","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1086\/503372","article-title":"Protection of Rhesus monkeys against dengue virus challenge after tetravalent live attenuated dengue virus vaccination","volume":"193","author":"Sun","year":"2006","journal-title":"J. Infect. Dis."},{"issue":"6","key":"10.1016\/j.biopha.2021.112304_bib120","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.4269\/ajtmh.16-0634","article-title":"Phase 1 randomized study of a tetravalent dengue purified inactivated vaccine in healthy adults in the United States","volume":"96","author":"Schmidt","year":"2017","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"5","key":"10.1016\/j.biopha.2021.112304_bib121","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.4269\/ajtmh.17-0627","article-title":"Phase I randomized study of a tetravalent dengue purified inactivated vaccine in healthy adults from Puerto Rico","volume":"98","author":"Diaz","year":"2018","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"1","key":"10.1016\/j.biopha.2021.112304_bib122","doi-asserted-by":"crossref","first-page":"132","DOI":"10.4269\/ajtmh.19-0738","article-title":"Safety and immunogenicity of an AS03B-adjuvanted inactivated tetravalent dengue virus vaccine administered on varying schedules to healthy U.S. adults: a phase 1\/2 randomized study","volume":"103","author":"Lin","year":"2020","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"9951","key":"10.1016\/j.biopha.2021.112304_bib123","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/S0140-6736(14)61060-6","article-title":"Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial","volume":"384","author":"Capeding","year":"2014","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.biopha.2021.112304_bib124","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1056\/NEJMoa1411037","article-title":"Efficacy of a tetravalent dengue vaccine in children in Latin America","volume":"372","author":"Villar","year":"2015","journal-title":"New Engl. J. Med."},{"issue":"4","key":"10.1016\/j.biopha.2021.112304_bib125","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJMoa1800820","article-title":"Effect of dengue serostatus on dengue vaccine safety and efficacy","volume":"379","author":"Sridhar","year":"2018","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.biopha.2021.112304_bib126","unstructured":"World Health Organization, Dengue Vaccines, 2018. \u3008https:\/\/www.who.int\/new-room\/q-a-detail\/dengue-vaccines\u3009."},{"issue":"10","key":"10.1016\/j.biopha.2021.112304_bib127","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1097\/INF.0000000000002830","article-title":"Immune response persistence and safety of a booster dose of the tetravalent dengue vaccine in adolescents and adults who previously completed the 3-dose schedule 4-5 years earlier in Latin America: a randomized placebo-controlled trial","volume":"39","author":"Coronel","year":"2020","journal-title":"Pediatr. Infect. Dis. J."},{"issue":"6","key":"10.1016\/j.biopha.2021.112304_bib128","doi-asserted-by":"crossref","first-page":"978","DOI":"10.4269\/ajtmh.2011.10-0592","article-title":"Efficacy of a tetravalent chimeric dengue vaccine (DENVax) in Cynomolgus macaques","volume":"84","author":"Osorio","year":"2011","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"7","key":"10.1016\/j.biopha.2021.112304_bib129","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005738","article-title":"Dengue virus NS1 disrupts the endothelial glycocalyx, leading to hyperpermeability","volume":"12","author":"Puerta-Guardo","year":"2016","journal-title":"PLoS Pathog."},{"issue":"10234","key":"10.1016\/j.biopha.2021.112304_bib130","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/S0140-6736(20)30414-1","article-title":"Efficacy of a tetravalent dengue vaccine in healthy children aged 4-16 years: a randomised, placebo-controlled, phase 3 trial","volume":"395","author":"Biswal","year":"2020","journal-title":"Lancet"},{"issue":"21","key":"10.1016\/j.biopha.2021.112304_bib131","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1056\/NEJMoa1903869","article-title":"Efficacy of a tetravalent dengue vaccine in healthy children and adolescents","volume":"381","author":"Biswal","year":"2019","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.biopha.2021.112304_bib132","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.coviro.2020.09.005","article-title":"Historical discourse on the development of the live attenuated tetravalent dengue vaccine candidate TV003\/TV005","volume":"43","author":"Durbin","year":"2020","journal-title":"Curr. Opin. Virol."},{"issue":"4","key":"10.1016\/j.biopha.2021.112304_bib133","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1586\/14760584.2016.1115727","article-title":"Development of TV003\/TV005, a single dose, highly immunogenic live attenuated dengue vaccine; what makes this vaccine different from the Sanofi-Pasteur CYD vaccine?","volume":"15","author":"Whitehead","year":"2016","journal-title":"Expert Rev. Vaccin."},{"issue":"5","key":"10.1016\/j.biopha.2021.112304_bib134","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/infdis\/jiv082","article-title":"Robust and balanced immune responses to all 4 dengue virus serotypes following administration of a single dose of a live attenuated tetravalent dengue vaccine to healthy, flavivirus-naive adults","volume":"212","author":"Kirkpatrick","year":"2015","journal-title":"J. Infect. Dis."},{"issue":"6","key":"10.1016\/j.biopha.2021.112304_bib135","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1093\/infdis\/jis936","article-title":"A single dose of any of four different live attenuated tetravalent dengue vaccines is safe and immunogenic in flavivirus-naive adults: a randomized, double-blind clinical trial","volume":"207","author":"Durbin","year":"2013","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.biopha.2021.112304_bib136","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/s41467-021-21384-0","article-title":"A tetravalent live attenuated dengue virus vaccine stimulates balanced immunity to multiple serotypes in humans","volume":"12","author":"Nivarthi","year":"2021","journal-title":"Nat. Commun."},{"issue":"42","key":"10.1016\/j.biopha.2021.112304_bib137","doi-asserted-by":"crossref","first-page":"7261","DOI":"10.1016\/j.vaccine.2011.07.019","article-title":"Development of dengue DNA vaccines","volume":"29","author":"Danko","year":"2011","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.biopha.2021.112304_bib138","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0264-410X(97)00215-6","article-title":"Inoculation of plasmids expressing the dengue-2 envelope gene elicit neutralizing antibodies in mice","volume":"15","author":"Kochel","year":"1997","journal-title":"Vaccine"},{"issue":"22","key":"10.1016\/j.biopha.2021.112304_bib139","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1016\/S0264-410X(99)00570-8","article-title":"Immunogenicity of dengue virus type 1 DNA vaccines expressing truncated and full length envelope protein","volume":"18","author":"Raviprakash","year":"2000","journal-title":"Vaccine"},{"issue":"27","key":"10.1016\/j.biopha.2021.112304_bib140","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1016\/S0264-410X(00)00105-5","article-title":"A dengue virus serotype-1 DNA vaccine induces virus neutralizing antibodies and provides protection from viral challenge in Aotus monkeys","volume":"18","author":"Kochel","year":"2000","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.biopha.2021.112304_bib141","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.vaccine.2010.11.050","article-title":"Evaluation of a prototype dengue-1 DNA vaccine in a Phase 1 clinical trial","volume":"29","author":"Beckett","year":"2011","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.biopha.2021.112304_bib142","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1007\/s007050050348","article-title":"Protective efficacy of a dengue 2 DNA vaccine in mice and the effect of CpG immuno-stimulatory motifs on antibody responses","volume":"143","author":"Porter","year":"1998","journal-title":"Arch. Virol."},{"issue":"5","key":"10.1016\/j.biopha.2021.112304_bib143","doi-asserted-by":"crossref","first-page":"420","DOI":"10.4269\/ajtmh.2001.65.420","article-title":"Characterization of antibody responses to combinations of a dengue-2 DNA and dengue-2 recombinant subunit vaccine","volume":"65","author":"Simmons","year":"2001","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"19","key":"10.1016\/j.biopha.2021.112304_bib144","doi-asserted-by":"crossref","first-page":"9577","DOI":"10.1128\/JVI.00284-06","article-title":"Characterization of antibody responses to combinations of a dengue virus type 2 DNA vaccine and two dengue virus type 2 protein vaccines in rhesus macaques","volume":"80","author":"Simmons","year":"2006","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.biopha.2021.112304_bib145","doi-asserted-by":"crossref","first-page":"849","DOI":"10.4269\/ajtmh.17-0416","article-title":"Safety and immunogenicity of a tetravalent dengue DNA vaccine administered with a cationic lipid-based adjuvant in a phase 1 clinical trial","volume":"98","author":"Danko","year":"2018","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.biopha.2021.112304_bib146","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/B978-0-12-800098-4.00007-6","article-title":"Dengue virus vaccine development","volume":"88","author":"Yauch","year":"2014","journal-title":"Adv. Virus Res."},{"issue":"2","key":"10.1016\/j.biopha.2021.112304_bib147","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.biotechadv.2010.11.008","article-title":"Review of dengue virus and the development of a vaccine","volume":"29","author":"Murrell","year":"2011","journal-title":"Biotechnol. Adv."},{"issue":"3","key":"10.1016\/j.biopha.2021.112304_bib148","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1128\/jvi.65.3.1400-1407.1991","article-title":"Carboxy-terminally truncated dengue virus envelope glycoproteins expressed on the cell surface and secreted extracellularly exhibit increased immunogenicity in mice","volume":"65","author":"Men","year":"1991","journal-title":"J. Virol."},{"issue":"27","key":"10.1016\/j.biopha.2021.112304_bib149","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1016\/S0264-410X(00)00121-3","article-title":"Immunization of rhesus monkeys with a recombinant of modified vaccinia virus Ankara expressing a truncated envelope glycoprotein of dengue type 2 virus induced resistance to dengue type 2 virus challenge","volume":"18","author":"Men","year":"2000","journal-title":"Vaccine"},{"issue":"41","key":"10.1016\/j.biopha.2021.112304_bib150","doi-asserted-by":"crossref","first-page":"6730","DOI":"10.1016\/j.vaccine.2010.07.073","article-title":"Pediatric measles vaccine expressing a dengue tetravalent antigen elicits neutralizing antibodies against all four dengue viruses","volume":"28","author":"Brandler","year":"2010","journal-title":"Vaccine"},{"issue":"14","key":"10.1016\/j.biopha.2021.112304_bib151","doi-asserted-by":"crossref","first-page":"6927","DOI":"10.1128\/JVI.02724-07","article-title":"A tetravalent dengue vaccine based on a complex adenovirus vector provides significant protection in rhesus monkeys against all four serotypes of dengue virus","volume":"82","author":"Raviprakash","year":"2008","journal-title":"J. Virol."},{"issue":"11","key":"10.1016\/j.biopha.2021.112304_bib152","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1089\/aid.1994.10.1443","article-title":"Immunogenicity of recombinant adenovirus-human immunodeficiency virus vaccines in chimpanzees following intranasal administration","volume":"10","author":"Lubeck","year":"1994","journal-title":"AIDS Res. Hum. Retrovir."},{"issue":"6","key":"10.1016\/j.biopha.2021.112304_bib153","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1128\/JVI.02298-12","article-title":"An alphavirus vector-based tetravalent dengue vaccine induces a rapid and protective immune response in macaques that differs qualitatively from immunity induced by live virus infection","volume":"87","author":"White","year":"2013","journal-title":"J. Virol."},{"issue":"21","key":"10.1016\/j.biopha.2021.112304_bib154","doi-asserted-by":"crossref","first-page":"11634","DOI":"10.1128\/JVI.00996-07","article-title":"A heterologous DNA prime-Venezuelan equine encephalitis virus replicon particle boost dengue vaccine regimen affords complete protection from virus challenge in cynomolgus macaques","volume":"81","author":"Chen","year":"2007","journal-title":"J. Virol."},{"issue":"32","key":"10.1016\/j.biopha.2021.112304_bib155","doi-asserted-by":"crossref","first-page":"4068","DOI":"10.1016\/j.vaccine.2014.05.053","article-title":"A tetravalent alphavirus-vector based dengue vaccine provides effective immunity in an early life mouse model","volume":"32","author":"Khalil","year":"2014","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.biopha.2021.112304_bib156","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nrmicro1690","article-title":"Prospects for a dengue virus vaccine","volume":"5","author":"Whitehead","year":"2007","journal-title":"Nat. Rev. Microbiol."},{"issue":"5","key":"10.1016\/j.biopha.2021.112304_bib157","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/QCO.0b013e32834a1b0b","article-title":"Critical issues in dengue vaccine development","volume":"24","author":"Thomas","year":"2011","journal-title":"Curr. Opin. Infect. Dis."},{"issue":"11","key":"10.1016\/j.biopha.2021.112304_bib158","doi-asserted-by":"crossref","first-page":"5847","DOI":"10.1128\/JVI.00216-15","article-title":"Dengue virus infection with highly neutralizing levels of cross-reactive antibodies causes acute lethal small intestinal pathology without a high level of viremia in mice","volume":"89","author":"Watanabe","year":"2015","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.biopha.2021.112304_bib159","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1086\/526790","article-title":"Cross-reactive memory CD8(+) T cells alter the immune response to heterologous secondary dengue virus infections in mice in a sequence-specific manner","volume":"197","author":"Beaumier","year":"2008","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.biopha.2021.112304_bib160","unstructured":"US. CDC, Dengue Vaccine, 2021. Website Avalibale at \u3008https:\/\/www.cdc.gov\/dengue\/prevention\/dengue-vaccine.html\u3009."},{"issue":"2","key":"10.1016\/j.biopha.2021.112304_bib161","doi-asserted-by":"crossref","first-page":"104","DOI":"10.7774\/cevr.2017.6.2.104","article-title":"Animal models for dengue vaccine development and testing","volume":"6","author":"Na","year":"2017","journal-title":"Clin. Exp. Vaccin. Res."},{"issue":"3","key":"10.1016\/j.biopha.2021.112304_bib162","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0092495","article-title":"Protection against dengue virus infection in mice by administration of antibodies against modified nonstructural protein 1","volume":"9","author":"Wan","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.biopha.2021.112304_bib163","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1096\/fj.12-213967","article-title":"XAF1 contributes to dengue virus-induced apoptosis in vascular endothelial cells","volume":"27","author":"Long","year":"2013","journal-title":"FASEB J."},{"issue":"5","key":"10.1016\/j.biopha.2021.112304_bib164","doi-asserted-by":"crossref","first-page":"989","DOI":"10.4269\/ajtmh.14-0162","article-title":"Correlation between serum levels of anti-endothelial cell autoantigen and anti-dengue virus nonstructural protein 1 antibodies in dengue patients","volume":"92","author":"Cheng","year":"2015","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"1","key":"10.1016\/j.biopha.2021.112304_bib165","doi-asserted-by":"crossref","first-page":"395","DOI":"10.4049\/jimmunol.174.1.395","article-title":"Expression of cytokine, chemokine, and adhesion molecules during endothelial cell activation induced by antibodies against dengue virus nonstructural protein 1","volume":"174","author":"Lin","year":"2005","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.biopha.2021.112304_bib166","article-title":"Vaccines and immunization strategies for dengue prevention","volume":"5","author":"Liu","year":"2016","journal-title":"Emerg. Microbes Infect."},{"issue":"2","key":"10.1016\/j.biopha.2021.112304_bib167","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003931","article-title":"Transmission-blocking antibodies against mosquito C-type lectins for dengue prevention","volume":"10","author":"Liu","year":"2014","journal-title":"PLoS Pathog."},{"issue":"10","key":"10.1016\/j.biopha.2021.112304_bib168","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005202","article-title":"Dengue virus infection of aedes aegypti requires a putative cysteine rich venom protein","volume":"11","author":"Londono-Renteria","year":"2015","journal-title":"PLoS Pathog."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222101088X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222101088X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:33:12Z","timestamp":1760099592000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333222101088X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":168,"alternative-id":["S075333222101088X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2021.112304","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targets and strategies for vaccine development against dengue viruses","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2021.112304","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"112304"}}